Literature DB >> 32785837

The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis.

Yujie Dong1, Qi Yang2, Baofeng Guo3, Jiajing Zhu4, Xiaojie Sun5.   

Abstract

The objective of this meta-analysis was performed to compare the effects of tacrolimus plus phototherapy in the treatment of patients with vitiligo. Relevant studies were identified by searching PubMed, Embase, and Web of Science databases. The main outcomes of interest included excellent response (≥ 75% repigmentation), good response (50-75% repigmentation), moderate response (25%-50% repigmentation), and poor response (< 25% repigmentation). Risk ratio (RR) with 95% confidence intervals (95% CIs) was used to calculate the data. Eleven studies were included in this study. Compared with phototherapy alone, combination treatment of tacrolimus and phototherapy significantly improved excellent response rate (RR = 1.40, 95% CI 1.16, 1.69; P < 0.001) and reduced the poor response rate (RR = 0.37, 95% CI 0.22, 0.61; P = 0.001). However, the good response rate (RR = 1.00, 95% CI 0.59, 1.69, P = 1.000) and moderate response rate (RR = 0.91, 95% CI 0.60, 1.38; P = 0.653) were not significantly different between the two treatments. Subgroup analysis suggested that combination treatment had a higher excellent response rate than phototherapy alone for lesions located in the face and proximal limbs. Both NB-UVB and EL, when added to tacrolimus, resulted in a significantly higher excellent response rate than they were used alone. Meta-regression analysis showed that age was a predictive factor that influenced the effect of combination treatment on an excellent response, in which children had a high excellent response to the treatment. Other demographic and clinical variables, including gender, disease duration, family history, and type of vitiligo, did not have any impact on the treatment effect. Combination treatment with tacrolimus and phototherapy was more effective than phototherapy monotherapy for patients with vitiligo, especially in the lesions located in the face and proximal limbs. More large-scale, well-performed trials are needed to verify our findings.

Entities:  

Keywords:  Meta-analysis; Phototherapy; Tacrolimus; Vitiligo

Mesh:

Substances:

Year:  2020        PMID: 32785837     DOI: 10.1007/s00403-020-02121-x

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  43 in total

Review 1.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

2.  Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.

Authors:  D Fai; N Cassano; G A Vena
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-08       Impact factor: 6.166

3.  Use of tacrolimus ointment in vitiligo alone or in combination therapy.

Authors:  S Berti; G Buggiani; T Lotti
Journal:  Skin Therapy Lett       Date:  2009-05

Review 4.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 5.  Vitiligo.

Authors:  Khaled Ezzedine; Viktoria Eleftheriadou; Maxine Whitton; Nanja van Geel
Journal:  Lancet       Date:  2015-01-15       Impact factor: 79.321

6.  Topical tacrolimus for treatment of childhood vitiligo in Asians.

Authors:  A J Kanwar; S Dogra; D Parsad
Journal:  Clin Exp Dermatol       Date:  2004-11       Impact factor: 3.470

Review 7.  Vitiligo. Pathogenesis and treatment.

Authors:  M D Njoo; W Westerhof
Journal:  Am J Clin Dermatol       Date:  2001       Impact factor: 7.403

8.  Nonsegmental vitiligo and autoimmune mechanism.

Authors:  Naoki Oiso; Tamio Suzuki; Kazuyoshi Fukai; Ichiro Katayama; Akira Kawada
Journal:  Dermatol Res Pract       Date:  2011-07-26

Review 9.  Oxidative stress and immune system in vitiligo and thyroid diseases.

Authors:  Roberta Colucci; Federica Dragoni; Silvia Moretti
Journal:  Oxid Med Cell Longev       Date:  2015-03-09       Impact factor: 6.543

Review 10.  A systematic review of natural health product treatment for vitiligo.

Authors:  Orest Szczurko; Heather S Boon
Journal:  BMC Dermatol       Date:  2008-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.